UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that ...

Transurethral cystolithotripsy and open surgery are associated with a high stone-free rate among bladder stone cases, though ...

The US Food and Drug Administration recently approved an alternative treatment option for patients with BCG-unresponsive high ...

UroGen Pharma Ltd. is a New York City-based commercial-stage biopharmaceutical concern focused on the development and marketing of therapies to treat cancer. The company markets two products ...

Boost ROI by targeting minimally invasive BPH devices, outpatient care and Asia-Pacific expansion while investing in innovation, physician training and strategic partnerships.Dublin, Oct. 13, 2026 ...

Transurethral resection of bladder tumor (TURBT) is an endoscopic procedure used to diagnose and remove abnormal tissue from the bladder. A surgeon passes a thin instrument called a resectoscope ...

MaxQ Medical has raised $31.5m to advance its ultrasound imaging and targeted therapy system for prostate care. The California-headquartered company's Series A financing round was led by led by ...

Financing supports first spinout of Orchard Ultrasound Innovation as MaxQ Medical advances its transurethral imaging and therapy system for BPH and prostate cancer "Men with prostate disease have had ...

Transurethral resection of bladder tumor (TURBT) is the standard for diagnosis and initial treatment of non-muscle-invasive bladder cancer (NMIBC) a disease with highly variable presentation. To ...

The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery embolization (PAE) to treat enlarged prostate (also called benign prostatic ...

(StatePoint) Word is spreading about the importance of enhanced detection in the management of bladder cancer. In a widely aired segment of “Viewpoint with Dennis Quaid,” patients shared their ...